PROAND ANTIANGIOGENIC FACTORS IN THE PATHOGENESIS OF EARLY PREGNANCY LOSSES. PART I. THE SPECIFIC FEATURES OF PROAND ANTIANGIOGENIC SERUM FACTORS IN EARLY PREGNANCY
- 作者: ZIGANSHINA M.M1, KRECHETOVA L.V1, VANKO L.V1, KHODZHAYEVA Z.S1, MUSIYENKO E.V1, SUKHIKH G.T1
-
隶属关系:
- Academician V.I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health and Social Development of Russia
- 期: 编号 3 (2012)
- 页面: 14-19
- 栏目: Articles
- URL: https://journals.eco-vector.com/0300-9092/article/view/246679
- ID: 246679
如何引用文章
详细
全文:

作者简介
M. ZIGANSHINA
Academician V.I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health and Social Development of Russia
Email: mmz@mail.ru
Moscow
L. KRECHETOVA
Academician V.I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health and Social Development of RussiaMoscow
L. VANKO
Academician V.I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health and Social Development of RussiaMoscow
Z. KHODZHAYEVA
Academician V.I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health and Social Development of RussiaMoscow
E. MUSIYENKO
Academician V.I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health and Social Development of RussiaMoscow
G. SUKHIKH
Academician V.I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health and Social Development of RussiaMoscow
参考
- Бурлев В.А., Зайдиева З.С., Ильясова Н.А. Регуляция ангиогенеза гестационного периода // Пробл. репрод. - 2008. - № 3. - С. 15-22.
- Внутриутробное развитие человека / Под ред. А.П. Милованова, С.В. Савельева. - М.: Медицина для всех, - 2006.
- Лазюк Г.И. Тератология человека. - М.: Медицина, 1991.
- Ранние сроки беременности / Под ред. В.Е. Радзинского, А.А. Оразмурадова. - М.: Status Praesens, 2009.
- Bai S.X., Wang Y.L., Qin L. et al. Dynamic expression of matrix metalloproteinases (MMP-2,-9 and -14) and the tissue inhibitors of MMPs (TIMP-1,-2 and -3) at the implantation site during tubal pregnancy // Reproduction. - 2005. -№ 129. - P. 103-113.
- Bates D.O. Vascular endothelial growth factors and vascular permeability // Cardiovasc. Res. - 2010. - № 87. -P. 262-271.
- Burton G.I., Charnock-Jones D.S., Jauniaux E. Regulation of vascular growth and function in the human placenta // Reproduction. - 2009. - № 138. - P. 895-902.
- Douglas N.C., Tang H., Gomez R. et al. Vascular endothelial growth factor receptor 2 (VEGF-2) functions to promote uterine decidual angiogenesis during early pregnancy in the mouse // Endocrinology. - 2009. - № 150. - P. 3845-3854.
- Florio P., Gabbanini M., Borges L.E. et al. Activins and related proteins in the establishment of pregnancy // Reprod. Sci. -2010. - № 17. - P. 320-330.
- Forbes K., Westwood M. Maternal growth factor regulation of human placental development and fetal growth // J. Endocrinol. - 2010. - № 207. - P. 1-16.
- Gabhann F.M., Popel A.S. Model of competitive binding of vascular endothelial growth factor and placental growth factor to VEGF receptors on endothelial cells // Am. J. Physiol. Heart Circ. Physiol. 2004. - № 286. - P. 153-164.
- Kalkunte S.S., Mselle N.F., Norris W.E. et al. Vascular endothelial growth factor C facilitates immune tolerance and endovascular activity of human uterine NK cells at the maternal-fetal interface // J. Immunol. - 2009. - № 182. -P. 4085-4092.
- Lorquet S., Pequeux C., Berndt S. et al. Implication of VEGF receptor soluble forms, sVEGFR-1 and sVEGFR-2, in pathological angiogenesis // Abstracts of the 23rd Annual Meeting of the ESHRE, Lyon, France, 1-4 July, 2007. -P. 1174-1175.
- Molshkness T.A., Stouffer R.L., Burry K.A. Circulating levels of free and total vascular endothelial growth factor (VEGF)-A, soluble VEGF recepror-1 and -2, and angiogenin during ovarian stimulation in non-human primates and women // Hum. Reprod. - 2004. - № 19. - P. 822-830.
- Naruse K., Lash G.E., Innes B. et al. Localization of matrix metalloproteinase (MMP)-2, MMP-9 and tissue inhibitors for MMPs (TIMPs) in uterine natural killer cells in early human pregnancy // Hum. Reprod. - 2008. - Vol. 23, № 1. -P. 1-9.
- Olson M.W., Gervasi D.C., Mobashery S., Fridman R. Kinetic analysis of the binding of human matrix metalloproteinase-2 and -9 to tissue inhibitor of metalloproteinase (TIMP-1) and (TIMP-2) // J. Biol. Chem. - 1997. - № 272. -P. 29975-29983.
- Plaisier M., Streefland E., Koolwijk P. et al. Angiogenic growth factors and their receptors in first-trimester human deciduas of pregnancies further complicated by preeclampsia or fetal growth restriction // Reprod. Sci. - 2008. - № 15. -P. 720-726.
- Plaisier M., Dennert I., Rost E. et al. Decidual vascularization and the expression of angiogenic growth factors and proteases in first trimester spontaneous abortions // Hum. Reprod. - 2009. - Vol. 24. - P.185-197.
- Sugimoto H., Hamano Y., Charytan D. et al. Neutralization of circulating vascular endothelial growth factor (VEGF) by anti-VEGF antibodies and soluble VEGF receptor 1 (sFlt-1) induced proteinuria // J. Biol. Chem. - 2003. - № 278. -P. 12605-12608.
- Wang A., Rana S., Karumanchi S.A. Preeclampsia: the role of angiogenic factors in its pathogenesis // Physiology. - 2009. -№ 24. - P. 147-158.
- Wathen K-A., Tuutti E., Stenman U-H. et al. Maternal serum-soluble vascular endothelial growth factor receptor-1 in early pregnancy ending in preeclampsia or intrauterine growth retardation // J. Clin. Endocrinol. Metab. - 2006. -№ 91. - P. 180-184.
- Wulff C., Weigand M., Kreienberg R., Fraser H.M. Angiogenesis during primate placentation in health and disease // Reproduction. - 2003. - № 126. - P. 569-577.
补充文件
